HIV

A Kaiser Family Foundation web briefing navigated the HIV/AIDS funding landscape, taking a look at trends over time, the latest data, and what we might expect in the future.

The National Cancer Institute (NCI) is sponsoring an ongoing clinical trial that evaluates pembrolizumab in people with HIV who have relapsed or refractory cancer and are also taking antiretroviral therapy. People with HIV are often excluded from participating in clinical trials of new cancer treatments because of concerns that treatments may be unsafe for them.

A woman gives birth after receivng a uterine transplant for the first time in the US; a once-monthly treatment for patients with poioid addiction gains FDA approval; and LA public health officials launch an initiative to reduce the annual number HIV infections.

Researchers find brake mechanism that prevents an essential shell from forming on virus that causes AIDS.

Countries in Southern and Eastern Africa have the highest prevalence of HIV worldwide. The Joint United Nations Program on HIV/AIDS strategy to end AIDS by 2030 has been dedicated to preventing HIV through voluntary medical male circumcision in Southern and Eastern African countries with HIV epidemics and low male circumcision prevalence.

The HIV Medicine Association of the Infectious Disease Society of America recently published clinical practice guidelines for managing chronic pain in patients with HIV.